Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

Vitreomacular Adhesion Clinical Trial

Official title:
A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion

Status Completed

Clinical Trial Summary

The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125µg dose in subjects wiht focal vitreomacular adhesion.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00781859
Study type	Interventional
Source	ThromboGenics
Contact
Status	Completed
Phase	Phase 3
Start date	December 2008
Completion date	April 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01966328` - A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment	Phase 1
Withdrawn	`NCT02001701` - Intravitreal Gas for Vitreomacular Adhesion	N/A
Completed	`NCT02322229` - Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion	Phase 4
Completed	`NCT02160340` - Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
Completed	`NCT00798317` - Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.	Phase 3
Completed	`NCT02035748` - Assessment of Patients Treated With JETREA® for Vitreomacular Traction	Phase 4